PureTech Health plc / Fundamentals
Income statement
- Net revenue
€6.59M - Cost of goods sold
€4.24M - Gross profit
€2.35M - SG&A expenses
€65.18M - R&D expenses
€129.38M - EBITDA
-€28.82M - D&A
€7.31M - EBIT
-€242.73M - Interest expenses
€20.21M - EBT
-€5.26M - Tax expenses
€22.72M - Net income
-€10.22M
Cash flow statement
- Net deferred tax
€22.17M - Non-cash items
-€238.25M - Changes in working capital
€6.15M - Operating cash flow
-€206.29M - Capex
€218.88K - Other investing cash flow
€29.97M - Net investing cash flow
€266.50M - Total cash dividends paid
€0.00 - Issuance of common stock
€771.09K - Debt repayment
€0.00 - Other financing cash flow
€120.30M - Net financing cash flow
€52.18M - Foreign exchange effects
-€430.77K - Net change in cash
€110.84M - Cash at end of period
€241.79M - Free cash flow
-€206.07M
Balance sheet
- Cash and cash equivalents
€241.79M - Cash and short-term investments
€316.45M - Total receivables
€11.12M - Inventory
€0.00 - Other current assets
€5.21M - Total current assets
€332.78M - Property, plant & equipment
€13.03M - Goodwill
€0.00 - Intangible assets
€517.79K - Long-term investments
€92.32M - Other non-current assets
€80.55M - Total non-current assets
€186.42M - Total assets
€519.20M - Accounts payable
€4.76M - Short-term debt
€6.63M - Other current liabilities
€24.21M - Total current liabilities
€35.66M - Long-term debt
€12.64M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€119.45M - Total non-current liabilities
€132.09M - Total liabilities
€167.75M - Common stock
€4.19M - Retained earnings
€27.99M - Other equity
€0.00 - Total equity
€351.45M - Total liabilities and shareholders' equity
€519.20M
Company information
- Market capitalization
€351.35M - Employees
80 - Enterprise Value
€218.37M
Company ratios
- Gross margin
-
35.7% Much better than peer group: -199.1% - EBITDA margin
-
-437.6% Much better than peer group: -941.6% - EBIT margin
-
-3,686.0% Much better than peer group: -6,105.1% - EBT margin
-
-79.8% Much better than peer group: -275,069.7% - Net margin
-
-155.2% Much worse than peer group: 1,643.5% - ROE
-
-2.9% Much better than peer group: -262.0% - ROA
-
-2.0% Much better than peer group: -290.3% - Asset turnover
-
1.3% Much worse than peer group: 121.3% - FCF margin
-
-3,135.9% Much better than peer group: -15,007.7% - FCF yield
-58.8% - Efficiency ratio
537.6% - Net sales per employee
-
€82.32K - Net income per employee
-
-€127.76K